Organ Damage Patterns in Advanced SM Linked to Disease Subtype
-
Emerging Solutions Could Make TK2d Easier to Recognize and TreatTK2d has long existed in a therapeutic void, with patients having few, if any, disease-modifying treatment options. -
SMA Continues to Challenge Patients Who Couldn’t Be Treated Early in InfancyLyza Weisman spoke at the recent MDA Clinical & Scientific Conference of no longer being able to do the 'little things' that make a life. -
PoNS Neurostimulation Device Helps to Treat Gait Problems, Patients With MS SayKerrie Walters first heard of PoNS in a chance encounter with TV personality Montel Williams, who also has MS and difficulties with gait. -
As Awareness of Huntington Grows Through Help 4 HD and Others, Hope Is BuildingLauren Holder, 39, was diagnosed with Huntington disease a year after her father died from it. -
Myasthenia Gravis, a Rare Disease, Is Rarer Still When It Strikes ChildrenTeenagers account for an estimated 10% to 15% of all MG cases in Europe and North America.
-
A Pompe Turning Point: Needing a WheelchairI went years without being on Pompe treatment, and walking became my most noticeable struggle.June 24, 2025 -
Ways to Make Life With Pompe EasierThe most common challenge that comes with living with Pompe disease is getting tired more easily.June 24, 2025
-
The Crucial Role Exercise Plays in Managing PompeThose of us living with Pompe disease know there’s a delicate balance between managing symptoms, maintaining physical function, and improving overall health.June 24, 2025 -
Don’t Let Pompe Disease Lead to Patient BurnoutPompe disease is a complex and multifaceted experience that affects virtually every aspect of daily life.June 24, 2025
-
Elderly Patients With ATTR-CM May Benefit From Tafamidis UseTafamidis appears to be effective in extending survival even among very elderly patients with transthyretin amyloid cardiomyopathy. -
Appraising Currently Available Therapeutic Strategies in ATTR-PNResearchers appraised the strengths of currently available therapeutic strategies in managing transthyretin amyloid polyneuropathy. -
Advancing SM Diagnosis With a Standardized ProtocolThere are gaps in SM diagnostics and researchers believe there would be advantages to implementing a system-wide screening algorithm. -
Exploring the Factors That Impact Prognosis in NMOSDAn early age of disease onset and the early initiation of treatment are both associated with an improved prognosis in NMOSD. -
Diagnosis of CIDP Revised to Leprosy NeuropathyA patient initially received a diagnosis of CIDP, but it was later reviewed to leprosy neuropathy.
- Achondroplasia
- Acute Lymphoblastic Leukemia
- Alagille Syndrome
- Alpha-1 Antitrypsin Deficiency
- ANCA-Associated Vasculitis
- Cholangiocarcinoma
- Chronic Inflammatory Demyelinating Polyneuropathy
- Chronic Lymphocytic Leukemia
- Cold Agglutinin Disease
- Cystic Fibrosis
- Diffuse Large B-Cell Lymphoma
- Dravet Syndrome
- Duchenne Muscular Dystrophy
- Fabry Disease
- Fetal and Neonatal Alloimmune Thrombocytopenia
- Friedreich Ataxia
- Gastrointestinal Stromal Tumor
- Gaucher Disease
- Generalized Pustular Psoriasis
- Hemolytic Disease of the Fetus and Newborn
- Hemophilia
- Hepatocellular Carcinoma
- Hereditary Angioedema
- Huntington Disease
- Idiopathic Pulmonary Fibrosis
- IgG4-Related Disease
- Immune Thrombocytopenia
- Lennox-Gastaut Syndrome
- Long Chain Fatty Acid Oxidation Disorder
- Lysosomal Acid Lipase Deficiency
- Medullary Thyroid Carcinoma
- Multiple Sclerosis
- Myasthenia Gravis
- Myelodysplastic Syndromes
- Myelofibrosis
- Neuromyelitis Optica Spectrum Disorder
- Paroxysmal Nocturnal Hemoglobinuria
- Pompe Disease
- Prader-Willi Syndrome
- Primary Biliary Cholangitis
- Primary Central Nervous System Lymphoma
- Pulmonary Arterial Hypertension
- Sickle Cell Disease
- Spinal Muscular Atrophy
- Systemic Mastocytosis
- Systemic Sclerosis
- Thymidine Kinase 2 Deficiency
- Transthyretin Amyloid Polyneuropathy
- Transthyretin-Mediated Amyloid Cardiomyopathy
- Wilson Disease
